Natural History of Mineral and Bone Disorders After Living-Donor Kidney Transplantation: A One-Year Prospective Observational Study

Therapeutic Apheresis and Dialysis

Volumn 15, Issue 5, 2011, Pages 481-487

  Kawarazaki, Hiroo ^a   Shibagaki, Yugo ^c   Fukumoto, Seiji ^a   Kido, Ryo ^a   Ando, Katsuyuki ^a   Nakajima, Ichiro ^b   Fuchinoue, Shohei ^b   Fujita, Toshiro ^a   Fukagawa, Masafumi ^d   Teraoka, Satoshi ^b  

^a UNIVERSITY OF TOKYO   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^c ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Fibroblast growth factor 23; Hypercalcemia; Hyperparathyroidism; Hypophosphatemia; Kidney transplantation

Indexed keywords

CALCIUM; FIBROBLAST GROWTH FACTOR 23; PARATHYROID HORMONE; PHOSPHATE;

ADULT; ARTICLE; BONE DISEASE; CALCIUM BLOOD LEVEL; CLINICAL ARTICLE; FEMALE; GRAFT RECIPIENT; HISTORY; HUMAN; HYPERCALCEMIA; HYPERPARATHYROIDISM; HYPOPHOSPHATEMIA; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LIVING DONOR; MALE; METABOLIC DISORDER; MULTIPLE LINEAR REGRESSION ANALYSIS; OBSERVATIONAL STUDY; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; PROSPECTIVE STUDY;

ADULT; CALCIUM; FEMALE; FIBROBLAST GROWTH FACTORS; HUMANS; HYPERCALCEMIA; HYPOPHOSPHATEMIA; KIDNEY TRANSPLANTATION; LINEAR MODELS; LIVING DONORS; MALE; MIDDLE AGED; PARATHYROID HORMONE; PHOSPHATES; PROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS;

EID: 80955177474     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2011.00932.x     Document Type: Article

References (16)

1. Messa P, Sindici C, Cannella G etal. Persistent secondary hyperparathyroidism after renal transplantation. Kidney Int 1998;54:1704-13.
2. Parffit A. Hypercalcemic hyperparathyroidism following renal transplantation: differential diagnosis, management. And implications for cell population control in the Parathyroid gland. Miner Electrolyte Metab 1982;8:92-110.
3. Ghanekar H, Welch B, Moe O, Sakhaee K. Post-renal transplantation hypophosphatemia: a review and novel insights. Curr Opin Nephrol Hypertens 2006;15:97-104.
4. Parffit A. The hyperparathyroidism of chronic renal failure: a disorder of growth. Kidney Int 1997;52:3-9.
5. McCarron D, Muther R, Lenfesty B, Bennett W. Parathyroid function in persistent hyperparathyroidism: relationship to gland size. Kidney Int 1982;22:662-70.
6. Bhan I, Shah A, Holmes J etal. Post-transplant hypophosphatemia: tertiary "Hyper-Phosphatoninism". Kidney Int 2006;70:1486-94.
7. Yamazaki Y, Okazaki R, Shibata M etal. Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia. J Clin Endocrinol Metab 2002;87:4957-60.
8. Perloff LJ, Spence RK, Grossman RA, Barker CF. Lethal post-transplantation calcinosis. Transplantation 1979;27:21-5.
9. Shigematsu T, Kazama J, Yamashita T etal. Possible involvement of circulating fibroblast growth factor-23 (FGF23) in the development of secondary hyperparathyroidism in pre-dialysis patients. Am J Kidney Dis 2004;44:250-6.
10. Evenepoel P, Lerut E, Naesens M etal. Localization, etiology and impact of calcium phosphate deposits in renal allografts. Am J Transplant 2009;9:2470-8.
11. Gwinner W, Suppa S, Mengel M etal. Early calcification of renal allografts detected by protocol biopsies: causes and clinical implications. Am J Transplant 2005;5:1934-41.
12. Frick TW, Fryd DS, Sutherland DE, Goodale RL, Simmons RL, Najarian JS. Hypercalcemia associated with pancreatitis and hyperamylasemia in renal transplant recipients. Data from the Minnesota randomized trial of cyclosporine versus antilymphoblast azathioprine. Am J Surg 1987;154:487-9.
13. Cunningham J. Posttransplant bone disease. Transplantation 2005;79:629-34.
14. Torres AV, Salido LE. Calcium Metabolism and Skeletal Problems after Transplantation. J Am Soc Nephrol 2002;13:551-8.
15. National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003;42:S1-201.
16. Torres A, Zarraga S, Rodríguez A etal. Optimum PTH levels before renal transplantation to prevent persistent hyperparathyroidism [abstract]. J Am Soc Nephrol 1998;9:572A.